Related Experiment Video
Updated: Jun 20, 2026
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
[Relationship between insulin resistance and bone metabolism]
1Division of Nephrology, Kobe University School of Medicine/Department of Nutrition, Kobe University Hospital.
Clinical Calcium
|September 2, 2009
Summary
Insulin resistance molecules, including adipocytokines and PPARs, significantly impact bone metabolism. Certain PPAR agonists, like rosiglitazone, are linked to increased bone fracture risk.
Area of Science:
- Endocrinology
- Bone Biology
- Metabolic Research
Background:
- Insulin is crucial for bone metabolism.
- Adipocytokines and peroxisome proliferator-activated receptors (PPARs) link insulin resistance to bone health.
- Concerns exist regarding PPAR agonists and bone health.
Purpose of the Study:
- To review the relationship between molecules involved in insulin resistance and bone metabolism.
- To highlight the impact of adipocytokines and PPARs on bone.
- To discuss the implications of PPAR agonists on bone fracture risk.
Main Methods:
- Literature review of studies on insulin resistance, adipocytokines, PPARs, and bone metabolism.
- Analysis of reports on the effects of specific PPAR agonists on bone density and fracture rates.
- Synthesis of current understanding of molecular mechanisms involved.
Main Results:
- Insulin resistance pathways significantly influence bone metabolism.
- Adipocytokines and PPARs play a key role in modulating bone.
- FDA warnings highlight increased bone fracture risk with rosiglitazone and pioglitazone (PPAR gamma agonists).
Conclusions:
- Molecules regulating insulin resistance are critical regulators of bone metabolism.
- Further research is needed to fully elucidate the mechanisms.
- Clinical vigilance is required for patients on PPAR agonists regarding bone health.
Related Concept Videos
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...